|From: rocket (Rep: 199) reply to singhtelecom||Date: 05/16/2018 23:34|
|Forum: Wall Street Pit - Msg #2734400 - List IMMU msgs ||Thread #674006374 (Rec: 0) |
|Had just bought in 18.32 right before it rocked up. Though I sold before the news came out with a nice profit. How does some know about the news before it is published? > Re: HE KNEW this great news Re: 1,600 June 20 calls bought from 1.30-1.35 above o...|
>>>>There are only two lifestyles, righteous or unrighteous. Only one will endure the limits of time.<<<<
>>>>Scars remind us of where we've been, they do not have to dictate where we are going.<<<<
>>>>If there is nothing above us we will be consumed by all that is around us.<<<<
>>>>Once you step out of bounds, then there are no bounds.<<<<
| Reply to singhtelecom - Msg #2734395 - 05/16/2018 22:16|
HE KNEW this great news Re: 1,600 June 20 calls bought from 1.30-1.35 above open interest of 212 contract...
reports 'positive' data for sacituzumab govitecan, its metastatic breast cancer drug (19.51 +0.73)
Co announces that sacituzumab govitecan, its lead investigational ADC, induced promising objective responses as a single agent in heavily pre-treated patients with estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative metastatic breast cancer.
Sacituzumab govitecan treatment was generally well tolerated, with no treatment-related deaths. Consistent with safety data obtained in metastatic TNBC, grade 3 or 4 toxicity with greater than 10 percent frequency included neutropenia and leukopenia. There was one case of grade 3/4 diarrhea and febrile neutropenia.
TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.